Search Tag: Masimo

2016 09 Sep

  Masimo  has announced that in a new study recently presented at the World Congress of Anesthesiologists (WCA) in Hong Kong, researchers concluded that continuous and noninvasive hemoglobin monitoring using Masimo SpHb® may reduce excessive intraoperative red blood cell (RBC) transfusion. 1 In a retrospective review of 371 patients who underwent...Read more

2016 04 Aug

Masimo  has announced the CE marking for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, helps clinicians monitor cerebral oxygenation. O3 regional oximetry uses near-infrared spectroscopy (NIRS) to continuously monitor absolute and trended regional...Read more

2016 28 Jul

Masimo  has announced that University Hospitals Geneva Medical Center (UH Geneva), a Critical Access Hospital in Geneva, Ohio, is building a hospital-wide wireless monitoring and clinician notification system using Masimo Patient SafetyNet™* in conjunction with Masimo Root® with Radius-7® and Masimo Radical-7®. UH Geneva is part of University Hospitals,...Read more

2016 28 Jul

Masimo  has announced that a new study of patients undergoing liver transplantation evaluated the relationship of PVI® to right ventricular end-diastolic volume (RVEDVI) and concluded that PVI provided a “reliable estimate of [cardiac] preload status and may be a useful predictor of fluid responsiveness.” 1  PVI measures the dynamic changes in perfusion...Read more

2016 15 Jul

Masimo  has announced that in a new study using the 1st Generation Masimo Pronto® Pulse CO-Oximeter®, which noninvasively measures total hemoglobin (SpHb®), researchers found that noninvasive and invasive measurements correlated well and that “[g]iven the rapid availability of results and the lack of requirement of venipuncture, noninvasive hemoglobin...Read more

2016 08 Jul

Masimo  has announced  that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry technologies to monitor patients in the operating room and intensive care unit. “Our non-profit hospital performs over 32,000 treatments each year. Easy...Read more

2016 28 Jun

Radius-7 is the First Wearable, Tetherless, Noninvasive rainbow® Monitor Masimo  has announced FDA 510(k) clearance for Radius-7® – the first and only wearable, tetherless, noninvasive rainbow® monitor. Radius-7, which connects to the Root® patient monitoring and connectivity platform, is now available in the U.S. with breakthrough Masimo rainbow® technoRead more

2016 23 Jun

Masimo and   SunTech Medical, a Halma (LSE:HLMA) company, jointly has announced the integration of Masimo SET® pulse oximetry technology into SunTech’s CT40, a next generation spot-check vital signs device. Masimo Signal Extraction Technology (SET®) Measure-through Motion and Low Perfusion™ pulse oximetry measures oxygen saturation (SpO2), pulse rate,...Read more

2016 13 Jun

Masimo  has announced FDA 510(k) clearance for O3™ regional oximetry. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain due to various factors, such as the type of clinical procedure being...Read more

2016 08 Jun

Masimo  has announced the full market release outside the U.S. of the Pronto® Pulse CO-Oximeter® with Next Generation SpHb® Spot Check technology. Next Generation Pronto features rainbow SET™ technology, for noninvasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI). In addition to the...Read more

2016 02 Jun

Masimo  has announced that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology) pulse oximetry at all locations. Motherhood Hospitals will also be screening for Critical Congenital Heart Disease (CCHD) using Masimo’s technology. “We are happy...Read more

2016 27 May

SedLine, Which Helps Clinicians Improve Anesthetic Management, Receives CE Mark Masimo  announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology's (ESA) 2016 Euroanaesthesia Congress in London, England. Next Generation SedLine enhances...Read more

2016 19 May

Fire-Service Based EMS Awards Presented at 28 th  Annual National Fire and Emergency Services Dinner The Congressional Fire Services Institute (CFSI) and   Masimo  honored two fire departments for best practices and innovative solutions in the delivery of emergency medical services with the Excellence in Fire Service-Based EMS Award. The award...Read more

2016 09 May

Q1 2016 Highlights (compared to Q1 2015): Total revenue, including royalties, rose 10.8% to $171.2 million Product revenue rose 10.8% to $163.3 million Masimo rainbow® revenue rose 39.2% to $16.9 million SET® and rainbow® SET® units shipments were 46,300 GAAP net income of $27.6 million, or $0.53 per diluted share versus $20.5 million, or $0.38...Read more

2016 21 Apr

Masimo (NASDAQ: MASI) has announced that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo’s Radical-7®, including noninvasive, continuous hemoglobin (SpHb®), Pleth Variability Index (PVI®), and SET® pulse oximetry technology, to monitor surgical patients and critical patients in the post-anesthesia care unit...Read more

2016 31 Mar

Masimo  has announced that a new retrospective study reports the relationship between Masimo’s Oxygen Reserve Index (ORI™) and arterial partial pressure of oxygen (PaO 2 ) during surgery. The study suggests that ORI may provide an advanced indication of impending desaturation in adults undergoing surgery based on trends in the relationship between...Read more

2016 22 Mar

Masimo  has announced that a new study reported on the accuracy of Masimo’s Blue® sensors as compared to Nellcor and Masimo Standard sensors for cyanotic children with blood oxygen saturation less than 85%. 1  Masimo’s Blue sensor was designed specifically for cyanotic infants and children with congenital heart disease. The study was performed at...Read more

2016 07 Mar

Patient Video Surveillance System Provides High-Definition Real-Time Imaging at the Bedside Masimo  has announced the debut of SafetyNet™Surveillance at the  HIMSS  (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las Vegas. SafetyNet Surveillance is a video surveillance system that provides real-time...Read more

2016 07 Mar

Integrated Medical Device Data Management Solution Designed to Fill the Gaps in Electronic Medical Records Masimo  has announced the debut of Iris™ Gateway, a server-based software solution for integrating medical device data, at the  HIMSS  (Healthcare Information and Management Systems Society) 2016 Annual Conference and Exhibition in Las Vegas....Read more

2016 07 Mar

Masimo  has announced that  Manipal Hospitals  is the first hospital in India to install Masimo Patient SafetyNet™, a remote monitoring and clinician notification system. "With Patient SafetyNet, we are now able to monitor a certain set of patients 24x7," said Gopal Devanahalli, Chief Operating Officer of Manipal Hospitals. "One of the key features...Read more

2016 07 Mar

Masimo  announced today FDA 510(k) clearance for noninvasive blood pressure and temperature measurements for the Root® patient monitoring and connectivity platform. Root with noninvasive blood pressure from SunTech Medical enables clinicians to measure arterial blood pressure for adult, pediatric, and neonatal patients, with three distinct measurement...Read more

2016 24 Feb

For Breath Rates Less Than or Equal to 4 Breaths Per Minute, RAM Showed 78% True Positives and 22% False Positives, While Capnography Showed 30% True Positives and 70% False Positives Masimo  (NASDAQ: MASI) has announced that Masimo's rainbow®Acoustic Monitoring (RAM™) was associated with fewer alarm events during planned moderate sedation in a...Read more

2016 24 Feb

Masimo  has announced that in a new clinical study, Masimo's Oxygen Reserve Index (ORI™), the first noninvasive and continuous parameter to provide insight into patients' oxygen reserve when they are receiving supplemental oxygen, helped clinicians in the early identification of impending desaturation in pediatric patients during induction of anesthesia....Read more

2016 25 Jan

Masimo  (NASDAQ: MASI) has announced that a member of its Board of Directors, Chairman of its Scientific Advisory Board, and its Chief Science Officer, Steven Barker, Ph.D., M.D., was honored with the 2016 J.S. Gravenstein Award recognizing lifetime achievement at this month's Society for Technology in Anesthesia (STA) Annual Meeting in Palm Beach,...Read more

2016 21 Jan

Masimo  has announced that in a new study that compared acoustic respiration rate (RRa®) from Masimo’s rainbow® Acoustic Monitoring (RAMTM) to respiration rate from conventional capnography, researchers concluded that RAM was useful for monitoring dental patients under intravenous anesthesia. 1 The Anesthesia Patient Safety Foundation(APSF) and The...Read more

2016 13 Jan

Masimo and Appalachian Regional Healthcare System announced that Watauga Medical Center in Boone is the first hospital in North Carolina to install Masimo Patient SafetyNet, a remote monitoring and clinician notification system, and Radius-7, a patient-worn monitor that is designed to allow for patient mobility along with continuous monitoring....Read more

2015 17 Dec

Masimo  (NASDAQ: MASI), a global innovator of noninvasive patient monitoring technologies has announced that retired Senator Tom Harkin, former five-term U.S. Senator and former Chairman of the Senate Health, Education, Labor and Pension (HELP) Committee, has been elected to Masimo’s Board of Directors. Senator Harkin retired from the U.S. Senate in January...Read more

2015 02 Nov

  Masimo  (NASDAQ: MASI) announced that a member of its Board of Directors, Chairman of its Scientific Advisory Board, and its Chief Science Officer, Dr. Steven Barker, Ph.D., M.D., was honored with the Harvey W. Weiley Lifetime Achievement Award at this month's Innovations and Applications of Monitoring Perfusion, Oxygenation, and Ventilation (IAMPOV)...Read more

2015 29 Oct

Masimo  (NASDAQ: MASI) announced that two new studies using Masimo technologies were presented at the American Society of Anesthesiologists (ASA) annual meeting in San Diego, California, October 24-28. The conference is the largest gathering of anesthesiologists in the world. Study Evaluating the EMMA Portable Capnometer in Children Under General...Read more

2015 13 Jul

Masimo Addresses the Inaccurate and Misleading Claims that Covidien Continues to Make Regarding Nellcor Pulse Oximetry Performance Masimo (NASDAQ: MASI), the inventor of measure-through motion and low perfusion pulse oximetry, has renewed its $1,000,000 (USD) performance guarantee that Masimo SET® Pulse Oximetry will outperform all Nellcor (part...Read more